Notably, Stryker was named the most admired medtech company in the world. Another major orthopedic and spine device manufacturer, Medtronic, also earned a spot. 1. Stryker Corp.
could impede demand for MDT’s diabetes care products. Medtronic presents an attractive opportunity for value and income investors, offering a strong combination of a robust underlying business ...
What Happened: Disclosed in a Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission, Martha, Chairman and CEO at Medtronic, executed a strategic derivative sale. This involved ...
Currently, Medtronic is carrying a Zacks Rank of #3 ... By the end of yesterday's trading, the Medical - Products industry had an average PEG ratio of 2.19. The Medical - Products industry ...
Medtronic (MDT) ended the recent trading session at $90.19, demonstrating a +1.05% swing from the preceding day's closing price. The stock outpaced the S&P 500's daily loss of 0.29%. Elsewhere, the ...